Compton Capital Management Inc Palatin Technologies Inc Transaction History

Compton Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 07, 2019	SELL	$0.78 - $1.09 $11,700 - $16,350	-15,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$0.98 - $1.64 $4,900 - $8,200	5,000 Added 50.0%	15,000 $17,000
Q2 2018 Aug 14, 2018	SELL	$0.91 - $1.45 $9,100 - $14,500	-10,000 Reduced 50.0%	10,000 $10,000
Q1 2018 May 11, 2018	BUY	$0.84 - $1.18 $5,880 - $8,260	7,000 Added 53.85%	20,000 $22,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,000	13,000 $6,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.01M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Compton Capital Management Inc with notifications on news.